Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 97 Results

Title
Intervention Indication Therapeutic Area Year Actions
Fordadistrogene movaparvovec for Duchenne muscular dystrophy Fordadistrogene movaparvovec Duchenne muscular dystrophy (DMD) Genetic Disorders , Musculoskeletal System 2022 View  |  Download
Gantenerumab for Alzheimer’s disease Gantenerumab Alzheimer's disease Neurology 2022 View  |  Download
Giredestrant with palbociclib for previously untreated advanced or metastatic breast cancer Giredestrant , Givosiran (ALN-AS1) , Palbociclib Breast cancer Breast Cancer 2022 View  |  Download
Glatiramer Acetate Depot for treating relapsing forms of multiple sclerosis in adults aged 18 to 55 years Glatiramer Acetate Depot (Copaxone) Multiple sclerosis (MS) Nephrology 2022 View  |  Download
Glucarpidase for methotrexate toxicity Glucarpidase (Voraxaze) Methotrexate toxicity during cancer therapy Oncology , Toxicology 2022 View  |  Download
Idecabtagene vicleucel for treating relapsed or
refractory multiple myeloma after 2 therapies
Idecabtagene vicleucel (Ide-cel; bb2121) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2022 View  |  Download
Ivosidenib for previously treated advanced cholangiocarcinoma Ivosidenib (Tibsovo; AG-120) Cholangiocarcinoma Gastrointestinal Cancer 2022 View  |  Download
Leniolisib for previously untreated activated phosphoinositide 3-kinase delta syndrome Leniolisib Activated PI3K delta syndrome Genetic Disorders 2022 View  |  Download
Lenvatinib and pembrolizumab with transarterial
chemoembolisation for treating hepatocellular
carcinoma
Lenvatinib (Kisplyx; E7080; lenvatinib mesilate) , Pembrolizumab (Keytruda; MK-3475) Hepatocellular carcinoma (HCC) Gastrointestinal Cancer 2022 View  |  Download
Lenvatinib with pembrolizumab for previously treated metastatic non-small cell lung cancer Lenvatinib (Kisplyx; E7080; lenvatinib mesilate) , Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications